Harvard Bioscience Inc (HBIO) — Financial Flexibility Index
Harvard Bioscience Inc (HBIO) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-236.00K (operating CF $-662.00K minus capex $426.00K) represents 0% of total liabilities ($67.89 Million). Check HBIO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Harvard Bioscience Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Harvard Bioscience Inc across 27 annual periods. See Harvard Bioscience Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Harvard Bioscience Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Harvard Bioscience Inc. For the full company profile including market capitalisation, see Harvard Bioscience Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | $7.84 Million | $6.73 Million | $66.34 Million | ▲ +59.1% |
| 2024 | 0.07x | $4.70 Million | $1.44 Million | $63.30 Million | ▼ -70.8% |
| 2023 | 0.25x | $16.34 Million | $14.03 Million | $64.29 Million | ▲ +577.9% |
| 2022 | 0.04x | $2.74 Million | $1.15 Million | $73.14 Million | ▲ +13.5% |
| 2021 | 0.03x | $2.61 Million | $1.26 Million | $78.94 Million | ▼ -74.9% |
| 2020 | 0.13x | $10.48 Million | $9.33 Million | $79.57 Million | ▲ +18.3% |
| 2019 | 0.11x | $9.26 Million | $8.05 Million | $83.18 Million | ▲ +187.2% |
| 2018 | 0.04x | $3.33 Million | $2.34 Million | $85.89 Million | ▼ -43.3% |
| 2017 | 0.07x | $1.95 Million | $1.06 Million | $28.45 Million | ▼ -64.5% |
| 2016 | 0.19x | $6.86 Million | $5.38 Million | $35.57 Million | ▲ +123.2% |
| 2015 | 0.09x | $3.68 Million | $705.00K | $42.62 Million | ▼ -45.0% |
| 2014 | 0.16x | $6.36 Million | $4.35 Million | $40.45 Million | ▲ +12.2% |
| 2013 | 0.14x | $5.74 Million | $4.06 Million | $40.98 Million | ▼ -58.6% |
| 2012 | 0.34x | $9.89 Million | $8.06 Million | $29.27 Million | ▲ +34.0% |
| 2011 | 0.25x | $7.85 Million | $6.35 Million | $31.14 Million | ▼ -33.7% |
| 2010 | 0.38x | $13.14 Million | $12.29 Million | $34.55 Million | ▼ -32.0% |
| 2009 | 0.56x | $17.89 Million | $16.51 Million | $31.97 Million | ▼ -22.5% |
| 2008 | 0.72x | $10.51 Million | $9.20 Million | $14.55 Million | ▲ +32.2% |
| 2007 | 0.55x | $13.51 Million | $12.05 Million | $24.72 Million | ▲ +8.6% |
| 2006 | 0.50x | $10.74 Million | $8.36 Million | $21.34 Million | ▲ +88.8% |
| 2005 | 0.27x | $6.29 Million | $5.20 Million | $23.62 Million | ▼ -34.5% |
| 2004 | 0.41x | $14.45 Million | $11.44 Million | $35.52 Million | ▲ +255.9% |
| 2003 | 0.11x | $3.38 Million | $2.03 Million | $29.55 Million | ▲ +4.2% |
| 2002 | 0.11x | $2.11 Million | $799.46K | $19.20 Million | ▼ -71.3% |
| 2001 | 0.38x | $5.93 Million | $4.10 Million | $15.55 Million | ▼ -11.0% |
| 2000 | 0.43x | $2.78 Million | $2.15 Million | $6.47 Million | ▲ +66.1% |
| 1999 | 0.26x | $3.26 Million | $2.93 Million | $12.63 Million | — |